ST Premium

For just $1, you can unlock ST Grading’s top-rated stocks that consistently beat the market.Our AI-powered Smart Screener finds winning trades in seconds, helping you uncover hidden opportunities before others do.

Ready to Win Big?

Try Now for Just $1!

XLO Company Profile and Key Details

NASDAQ : XLO

Xilio Therapeutics, Inc.

$0.67

-0.0068-1.00%

At Close 4:00 PM

$0.76

0.0823+12.23%

Pre-Market 08:30 PM

59.03

BESG ScoreESG Rating

Profile Key Stats Analyst Ratings Ownership Ratios Financials Dividend & splits Sentiment Forecast

XLO Stock Price Chart

Stock Price Today

Xilio Therapeutics, Inc. (XLO) stock declined over -1.00%, trading at $0.67 on NASDAQ, down from the previous close of $0.68. The stock opened at $0.66, fluctuating between $0.62 and $0.69 in the recent session.

Stock Snapshot

0.6797

Prev. Close

0.66

Open

34.84M

Market Cap

51.77M

Number of Shares

0.62

Day Low

0.6871

Day High

-0.62

P/E Ratio

42.49%

Free Float in %

-1.09

EPS (TTM)

1.34

Book Value

-2.51

Cash Flow per Share

272.41K

Volume

Stock Price History Chart

Date	Open	High	Low	Close	Volume
Apr 07, 2025	0.66	0.69	0.62	0.67	272.48K
Apr 04, 2025	0.71	0.73	0.67	0.70	304.92K
Apr 03, 2025	0.71	0.75	0.70	0.70	196.56K
Apr 02, 2025	0.68	0.74	0.68	0.74	220.9K
Apr 01, 2025	0.73	0.74	0.68	0.68	262.48K
Mar 31, 2025	0.74	0.74	0.71	0.72	178.35K
Mar 28, 2025	0.73	0.75	0.69	0.75	308.92K
Mar 27, 2025	0.71	0.77	0.71	0.73	338.6K
Mar 26, 2025	0.76	0.77	0.73	0.73	285.5K
Mar 25, 2025	0.78	0.79	0.75	0.76	135.33K
Mar 24, 2025	0.81	0.81	0.74	0.79	372.15K
Mar 21, 2025	0.78	0.79	0.75	0.79	168.62K
Mar 20, 2025	0.78	0.82	0.75	0.78	174.51K
Mar 19, 2025	0.80	0.80	0.76	0.79	186.35K
Mar 18, 2025	0.81	0.81	0.76	0.78	333.94K
Mar 17, 2025	0.80	0.82	0.78	0.81	345.04K
Mar 14, 2025	0.84	0.87	0.77	0.80	1.53M
Mar 13, 2025	0.82	0.82	0.76	0.80	290.03K
Mar 12, 2025	0.79	0.83	0.76	0.83	375.83K
Mar 11, 2025	0.83	0.84	0.73	0.79	1.24M

Contact Details

Waltham, MA 02451

United States

Website: https://www.xiliotx.comContact: 617 430 4680

About Company

Xilio Therapeutics, Inc., a clinical-stage biotechnology company, develops immunotherapies to improve the immune system of cancer patients. Its checkpoint inhibitor program includes XTX101, a clinical-stage, tumor-selective anti-CTLA-4 mAb that is in Phase 1/2 clinical trials in patients with solid tumors. The company also develops cytokine programs, which comprises XTX202, a modified form of IL-2; XTX301, an IL-12 product candidate; and XTX401, an IL-15 product candidate that are masked with a protein domain to prevent binding activity until cleaved off by tumor microenvironment (TME)-associated proteases. Xilio Therapeutics, Inc. was founded in 2016 and is headquartered in Waltham, Massachusetts.

Frequently Asked Questions

What is the current Xilio Therapeutics, Inc. (XLO) stock price?

Xilio Therapeutics, Inc. (NASDAQ: XLO) stock price is $0.67 in the last trading session. During the trading session, XLO stock reached the peak price of $0.69 while $0.62 was the lowest point it dropped to. The percentage change in XLO stock occurred in the recent session was -1% while the dollar amount for the price change in XLO stock was -$0.01.

XLO's industry and sector of operation?

The NASDAQ listed XLO is part of Biotechnology industry that operates in the broader Healthcare sector. Xilio Therapeutics, Inc. designs, manufactures, and markets smartphones, personal computers, tablets, wearables, and accessories worldwide.

Who are the executives of XLO?

Dr. Uli Bialucha Ph.D.
Chief Scientific Officer
Mr. Christopher Frankenfield
Chief Operating Officer
Mr. Bill Avery Ph.D.
Senior Vice President of Nonclinical Devel.
Mr. Edward C. English
Vice President of Fin. & Accounting, Treasury and Principal Accounting Officer
Dr. Rene Russo BCPS, Pharm.D, Pharm.D.
Chief Executive Officer & Director
Dr. Martin H. Huber M.D.
Pres and Head of R&D
Mr. Kevin M. Brennan
Senior Vice President of Fin. & Accounting and Director
Julissa Viana
Vice President of Corporation Communications
Ms. Stacey J. Davis
Chief Bus. Officer

How XLO did perform over past 52-week?

XLO's closing price is 8.53% higher than its 52-week low of $0.62 where as its distance from 52-week high of $1.70 is -60.42%.

How many employees does XLO have?

Number of XLO employees currently stands at 64.

Link for XLO official website?

Official Website of XLO is: https://www.xiliotx.com

How do I contact XLO?

XLO could be contacted at phone 617 430 4680 and can also be accessed through its website. XLO operates from 828 Winter Street, Waltham, MA 02451, United States.

How many shares of XLO are traded daily?

XLO stock volume for the day was 272.41K shares. The average number of XLO shares traded daily for last 3 months was 3.93M.

What is the market cap of XLO currently?

The market value of XLO currently stands at $34.84M with its latest stock price at $0.67 and 51.77M of its shares outstanding.

Stocks Telegraph provides information and tools designed to assist investors and Wall Street players. A major goal is to offer financiers comprehensive information that will help them gain insight into investing.

About

Home About Meet The Team Contact Us Privacy Policy Newsletter

Employees	64
Beta	-0.34
Sales or Revenue	$0.00
5Y Sales Change%	0%
Fiscal Year Ends	December
Sector	Healthcare
Industry	Biotechnology